Metabolomics and Detection of Colorectal Cancer in Humans: A Systematic Review
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ramsoekh D , van LeerdamME, van BallegooijenM, HabbemaJDF, KuipersEJ: Population screening for colorectal cancer: faeces, endoscopes or x-rays?Cell. Oncol.23(3), 185–194 (2007).
Wang H , SlupskyC, SawyerM, WongC, SchillerD, FedorakR: The role of NMR urine metabolomics as a new method for screening colorectal cancer – a preliminary analysis.Can. J. Gastroenterol.23(Suppl. A) (2009) (Abstract 144).
Broadhurst DI , BrownM, DunnWBet al.: The application of UPLC/LTQ-Orbitrap mass spectrometry to human metabolite biomarker discovery. A case study: pre-eclampsia.Reprod. Sci.15(2), 208A–208A (2008).
Siffedeen JS , RankinKN, FuH, DielemanLA, SlupskyC, FedorakR: Metabolomics in inflammatory bowel disease: differentiating patients with or without IBD.Gastroenterology134(4), A203–A203 (2008).
Ma Y QinH LiuWet al.: Ultra-high performance liquid chromatography-mass spectrometry for the metabolomic analysis of urine in colorectal cancer.Dig. Dis. Sci.1–8 (2008).
Piotto M MoussalliehF DillmannBet al.: Metabolic characterization of primary human colorectal cancers using high resolution magic angle spinning 1 H magnetic resonance spectroscopy.Metabolomics1–10 (2008).
